2,797 Shares in McKesson Corporation $MCK Purchased by Aurora Investment Counsel

Key Points

• Aurora Investment Counsel purchased 2,797 McKesson shares worth approximately $2.11 million in the second quarter, while institutional investors and hedge funds collectively own 85.07% of the stock.
• Analysts maintain a generally positive outlook, with 14 Buy ratings and four Holds producing a “Moderate Buy” consensus and an average price target of $973.44.
• McKesson exceeded quarterly expectations with $9.93 in EPS and $105.38 billion in revenue, while raising its quarterly dividend from $0.82 to $0.94 per share.

Aurora Investment Counsel purchased a new stake in shares of McKesson Corporation (NYSE:MCK - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,797 shares of the company's stock, valued at approximately $2,113,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MCK. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of McKesson during the fourth quarter worth approximately $25,000. Swiss RE Ltd. acquired a new position in shares of McKesson in the 4th quarter worth approximately $26,000. State of Wyoming acquired a new position in shares of McKesson in the 2nd quarter worth approximately $29,000. Kingdom Financial Group LLC. bought a new stake in McKesson during the 4th quarter worth approximately $33,000. Finally, Birchwood Financial Partners Inc. acquired a new stake in McKesson during the 4th quarter valued at $33,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on MCK. William Blair started coverage on McKesson in a research report on Tuesday, April 28th. They issued an "outperform" rating for the company. TD Cowen increased their target price on McKesson from $989.00 to $1,006.00 and gave the stock a "buy" rating in a report on Thursday, August 6th. Wall Street Zen lowered McKesson from a "buy" rating to a "hold" rating in a research note on Saturday, June 27th. Evercore reaffirmed an "outperform" rating on shares of McKesson in a report on Thursday, August 6th. Finally, Weiss Ratings downgraded shares of McKesson from a "buy (b)" rating to a "buy (b-)" rating in a research report on Tuesday, July 7th. Fourteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $973.44.

McKesson Stock Performance

Shares of MCK stock opened at $853.53 on Thursday. McKesson Corporation has a 52-week low of $673.38 and a 52-week high of $999.00. The stock has a market cap of $99.51 billion, a PE ratio of 22.84, a PEG ratio of 1.71 and a beta of 0.30. The firm's 50 day moving average price is $818.34 and its two-hundred day moving average price is $843.66.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, beating the consensus estimate of $9.56 by $0.37. The company had revenue of $105.38 billion during the quarter, compared to analysts' expectations of $103.88 billion. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The business's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $8.26 EPS. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, sell-side analysts predict that McKesson Corporation will post 44.65 earnings per share for the current fiscal year.

McKesson Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Tuesday, September 1st will be issued a $0.94 dividend. This is a boost from McKesson's previous quarterly dividend of $0.82. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Tuesday, September 1st. McKesson's dividend payout ratio is currently 8.78%.

Insiders Place Their Bets

In other news, EVP Michele Lau sold 3,550 shares of the business's stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at approximately $2,471,259.23. The trade was a 52.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the company's stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $764.00, for a total value of $101,612.00. Following the completion of the sale, the chief accounting officer directly owned 632 shares of the company's stock, valued at approximately $482,848. This trade represents a 17.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 29,049 shares of company stock valued at $22,530,626 in the last ninety days. 0.06% of the stock is currently owned by insiders.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source